ArticleJAMA oncology2022

Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung Cancer.

Lu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.